MIRCERA 250 MCG/0.3 ML
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 250 MCG / 0.3 ML
Available from:
ROCHE PHARMACEUTICALS (ISRAEL) LTD
ATC code:
B03XA03
Pharmaceutical form:
SOLUTION FOR INJECTION
Administration route:
I.V, S.C
Manufactured by:
ROCHE DIAGNOSTICS GmbH ,GERMANY
Therapeutic group:
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA
Therapeutic indications:
Treatment of anemia associated with chronic kidney disease (CKD).
Authorization date:
2013-04-01
